Kristian W. Antonsen, Niels Katballe, Daniel W. Kjær, Thomas D. Christensen, Holger J. Møller, Tua Gyldenholm. Serum soluble signal regulatory protein alpha as a potential prognostic biomarker after surgery for esophageal cancer. // Clinical Immunology. – DOI: 10.1016/j.clim.2026.110784. – URL: https://www.sciencedirect.com/science/article/pii/S1521661626001221?dgcid=rss_sd_all
Kristian W. Antonsen, Niels Katballe, Daniel W. Kjær, Thomas D. Christensen, Holger J. Møller, & Tua Gyldenholm Serum soluble signal regulatory protein alpha as a potential prognostic biomarker after surgery for esophageal cancer. Clinical Immunology. https://doi.org/10.1016/j.clim.2026.110784
Kristian W. Antonsen, et al. “Serum soluble signal regulatory protein alpha as a potential prognostic biomarker after surgery for esophageal cancer.” Clinical Immunology. doi:10.1016/j.clim.2026.110784.
@article{Antonsen,
title = {Serum soluble signal regulatory protein alpha as a potential prognostic biomarker after surgery for esophageal cancer},
author = {Antonsen, Kristian W. and Katballe, Niels and Kjær, Daniel W. and Christensen, Thomas D. and Møller, Holger J. and Gyldenholm, Tua},
journal = {Clinical Immunology},
doi = {10.1016/j.clim.2026.110784},
url = {https://www.sciencedirect.com/science/article/pii/S1521661626001221?dgcid=rss_sd_all}
}